Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084)

PHASE4WithdrawnINTERVENTIONAL

Timeline

Start Date

May 31, 2015

Primary Completion Date

October 31, 2019

Study Completion Date

October 31, 2019

Conditions

Hepatitis BHepatitis A

Interventions

PROCEDURE

Blood sampling

At Years 16 - 20 after first dose of the primary vaccination in HAB-084 (208127/084) study.

Trial Locations (1)

GSK Investigational Site, Hradec Králové